Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marston Linehan

Showing results (261-270 of 487) with videos related to

Pageof 49
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2004
Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissuesMichelle B Warren, Carlos A Torres-Cabala, Maria L Turner, et al.
Genes & Development|November 16, 2019
Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunityHaruki Horiguchi, Tsuyoshi Kadomatsu, Ryoma Kurahashi, et al.
Cell Reports|February 13, 2020
A FLCN-TFE3 Feedback Loop Prevents Excessive Glycogenesis and Phagocyte Activation by Regulating Lysosome ActivityMitsuhiro Endoh, Masaya Baba, Tamie Endoh, et al.
Urologic Oncology|February 17, 2015
Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genesVictoria L Martucci, Zarina G Lorenzo, Michael Weintraub, et al.
Journal of the National Cancer Institute|June 16, 2005
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumorsCathy D Vocke, Youfeng Yang, Christian P Pavlovich, et al.
BJU International|November 8, 2012
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancerNitin K Yerram, Dmitry Volkin, Baris Turkbey, et al.
Molecular Therapy. Nucleic Acids|September 2, 2025
Targeting a pathogenic cryptic exon that drives HLRCC to induce exon skippingSiddhardha S Maligireddy, Mariana D Mandler, Judith C Lunger, et al.
Clinical Chemistry|January 26, 2011
Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytomaGraeme Eisenhofer, Jacques W M Lenders, Henri Timmers, et al.
Journal of the National Cancer Institute|February 16, 2006
Gene promoter methylation in prostate tumor-associated stromal cellsJeffrey A Hanson, John W Gillespie, Amelia Grover, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer researchJ Carl Barrett, L Michelle Bennett, Laura Kay Fleming, et al.
Pageof 49

Showing results (261-270 of 487) with videos related to

Sort By:
Pageof 49
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2004
Expression of Birt-Hogg-Dubé gene mRNA in normal and neoplastic human tissuesMichelle B Warren, Carlos A Torres-Cabala, Maria L Turner, et al.
Genes & Development|November 16, 2019
Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunityHaruki Horiguchi, Tsuyoshi Kadomatsu, Ryoma Kurahashi, et al.
Cell Reports|February 13, 2020
A FLCN-TFE3 Feedback Loop Prevents Excessive Glycogenesis and Phagocyte Activation by Regulating Lysosome ActivityMitsuhiro Endoh, Masaya Baba, Tamie Endoh, et al.
Urologic Oncology|February 17, 2015
Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genesVictoria L Martucci, Zarina G Lorenzo, Michael Weintraub, et al.
Journal of the National Cancer Institute|June 16, 2005
High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumorsCathy D Vocke, Youfeng Yang, Christian P Pavlovich, et al.
BJU International|November 8, 2012
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancerNitin K Yerram, Dmitry Volkin, Baris Turkbey, et al.
Molecular Therapy. Nucleic Acids|September 2, 2025
Targeting a pathogenic cryptic exon that drives HLRCC to induce exon skippingSiddhardha S Maligireddy, Mariana D Mandler, Judith C Lunger, et al.
Clinical Chemistry|January 26, 2011
Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytomaGraeme Eisenhofer, Jacques W M Lenders, Henri Timmers, et al.
Journal of the National Cancer Institute|February 16, 2006
Gene promoter methylation in prostate tumor-associated stromal cellsJeffrey A Hanson, John W Gillespie, Amelia Grover, et al.
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Linking laboratory and clinical research: the development of molecularly targeted therapeutics inside the national cancer institute center for cancer researchJ Carl Barrett, L Michelle Bennett, Laura Kay Fleming, et al.
Pageof 49